Skip to main content
. 2014 Nov 12;160(1):225–234. doi: 10.1007/s00705-014-2270-5

Fig. 4.

Fig. 4

GSK-3β knockdown protects against IAV-induced suppression of β-catenin. A. Representative immunoblots (from three separate experiments) of GSK-3β and β-catenin in cell lysates (20 μg protein/lane) of HUVECs pre-treated with or without GSK-3β knockdown under control (no-infection) and IAV-infection conditions. B. Relative levels of GSK-3β and β-catenin in the bolt in panel A (n = 3). Differences between groups were analyzed using the unpaired t-test